| Lincare Inc | |
| 5 Highland Ave, Unit E, Bethlehem, Pennsylvania 18017 | |
| (610) 814-2344 |
| Name | Lincare Inc |
|---|---|
| Organization Name | Lincare Inc |
| Location | 5 Highland Ave, Unit E, Bethlehem, Pennsylvania 18017 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (610) 814-2344 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The U.S. Food and Drug Administration has scheduled a two-day public hearing on Nov. 2-3, 2010, on the implementation of the Biologics Price Competition and Innovation (BPCI) Act of 2009. The hearing will be held from 8:30 a.m. to 4:30 p.m. at the FDA's White Oak Campus, 10903 New Hampshire Ave., Building 31, room 1503, in Silver Spring, Md.
Today the U.S. Food and Drug Administration (FDA) released two separate draft guidance documents to help fight the tobacco epidemic and stop children from using tobacco. The draft guidance documents implement provisions of the Family Smoking Prevention and Tobacco Control Act that will ultimately provide the public with previously unknown information about the chemicals in tobacco products and help prevent misleading marketing about the risks associated with tobacco products.
For the first time, a team of international researchers have mapped the family trees of cancer cells in acute myeloid leukemia to understand how this blood cancer responds to a new drug, enasidenib.
Scientists have discovered a new cause of spastic ataxia, and believe this cause is also a trigger for other mitochondrial diseases neurological disorders that can lead to serious coordination, growth, visual, speech, and muscle defects.
› Verified 4 days ago
| NPI Number | 1558447144 |
| Organization Name | LINCARE INC |
| Doing Business As | PREFERRED HOME CARE |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 5 Highland Ave, Unit E, Bethlehem, PA 18017 |
| Phone Number | 610-814-2344 |
News Archive
The U.S. Food and Drug Administration has scheduled a two-day public hearing on Nov. 2-3, 2010, on the implementation of the Biologics Price Competition and Innovation (BPCI) Act of 2009. The hearing will be held from 8:30 a.m. to 4:30 p.m. at the FDA's White Oak Campus, 10903 New Hampshire Ave., Building 31, room 1503, in Silver Spring, Md.
Today the U.S. Food and Drug Administration (FDA) released two separate draft guidance documents to help fight the tobacco epidemic and stop children from using tobacco. The draft guidance documents implement provisions of the Family Smoking Prevention and Tobacco Control Act that will ultimately provide the public with previously unknown information about the chemicals in tobacco products and help prevent misleading marketing about the risks associated with tobacco products.
For the first time, a team of international researchers have mapped the family trees of cancer cells in acute myeloid leukemia to understand how this blood cancer responds to a new drug, enasidenib.
Scientists have discovered a new cause of spastic ataxia, and believe this cause is also a trigger for other mitochondrial diseases neurological disorders that can lead to serious coordination, growth, visual, speech, and muscle defects.
› Verified 4 days ago
News Archive
The U.S. Food and Drug Administration has scheduled a two-day public hearing on Nov. 2-3, 2010, on the implementation of the Biologics Price Competition and Innovation (BPCI) Act of 2009. The hearing will be held from 8:30 a.m. to 4:30 p.m. at the FDA's White Oak Campus, 10903 New Hampshire Ave., Building 31, room 1503, in Silver Spring, Md.
Today the U.S. Food and Drug Administration (FDA) released two separate draft guidance documents to help fight the tobacco epidemic and stop children from using tobacco. The draft guidance documents implement provisions of the Family Smoking Prevention and Tobacco Control Act that will ultimately provide the public with previously unknown information about the chemicals in tobacco products and help prevent misleading marketing about the risks associated with tobacco products.
For the first time, a team of international researchers have mapped the family trees of cancer cells in acute myeloid leukemia to understand how this blood cancer responds to a new drug, enasidenib.
Scientists have discovered a new cause of spastic ataxia, and believe this cause is also a trigger for other mitochondrial diseases neurological disorders that can lead to serious coordination, growth, visual, speech, and muscle defects.
› Verified 4 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2041 Avenue C 400, Bethlehem, Pennsylvania 18017 Phone: (610) 266-6333 | |
Cvs Pharmacy # 02459 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 305 West Fourth Street, Bethlehem, Pennsylvania 18015 Phone: (610) 691-4085 | |
Cvs Pharmacy # 01908 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 327 Woodlawn Avenue, Bethlehem, Pennsylvania 18018 Phone: (610) 691-4460 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5 Highland Ave, Bethlehem, Pennsylvania 18017 Phone: (610) 814-2344 | |
Rite Aid Pharmacy 11042 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2178 W Union Blvd, Bethlehem, Pennsylvania 18018 Phone: (610) 867-1004 |